These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 19318628
1. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. J Natl Cancer Inst; 2009 Apr 01; 101(7):475-87. PubMed ID: 19318628 [Abstract] [Full Text] [Related]
2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM. Lancet Oncol; 2011 Sep 01; 12(9):880-90. PubMed ID: 21865084 [Abstract] [Full Text] [Related]
3. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination. Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM. Int J Cancer; 2017 Oct 15; 141(8):1576-1584. PubMed ID: 28677147 [Abstract] [Full Text] [Related]
5. Primary and secondary prevention of cervical cancer--opportunities and challenges. Markowitz LE, Unger ER, Saraiya M. J Natl Cancer Inst; 2009 Apr 01; 101(7):439-40. PubMed ID: 19318638 [No Abstract] [Full Text] [Related]
15. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Cancer Epidemiol Biomarkers Prev; 2010 Jul 03; 19(7):1675-81. PubMed ID: 20615885 [Abstract] [Full Text] [Related]
16. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China. Zhang J, Zhang D, Yang Z, Wang X, Wang D. BMC Cancer; 2020 May 19; 20(1):443. PubMed ID: 32429919 [Abstract] [Full Text] [Related]
18. Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S, CVT Vaccine Group. J Natl Cancer Inst; 2011 Oct 05; 103(19):1444-51. PubMed ID: 21908768 [Abstract] [Full Text] [Related]
19. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. Powell N, Boyde A, Tristram A, Hibbitts S, Fiander A. Int J Cancer; 2009 Nov 15; 125(10):2425-7. PubMed ID: 19585507 [Abstract] [Full Text] [Related]